Blood rheology after renal transplantation?

Nephron

Volumn 74, Issue 2, 1996, Pages 328-332

  Koppensteiner, Renate ^a   Derfler, Kun ^a   Ehringer, Herbert ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Blood rheology; Hemodialysis; Renal transplantation; Rheological variables

Indexed keywords

FIBRINOGEN;

ADULT; AGED; ARTICLE; BLOOD FLOW; BLOOD RHEOLOGY; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; ERYTHROCYTE AGGREGATION; FEMALE; FIBRINOGEN BLOOD LEVEL; HEMATOCRIT; HEMODIALYSIS; HUMAN; KIDNEY TRANSPLANTATION; MALE; PLASMA VISCOSITY; PRIORITY JOURNAL; SURVIVAL; THROMBOCYTE AGGREGATION;

EID: 0029794568     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000189330     Document Type: Article

References (24)

1. Ibcls LS, Stewart JH. Mahony JF. Sheil AGR: Deaths from occlusive arterial disease in renal allograft recipients. Br Med J 1974;vol iii:552- 554.
2. I-owe GDO. Drummond MM. Lorimer AR. Hutton I, Forbes CD. Prentice CRM. Barbenel JC: Relation between extent of coronary artery disease and blood viscosity. Br Med J 1980: 280:673-674.
3. Dintenfass L, Ibels LS: Blood viscosity factors and occlusive arterial disease in renal transplant recipients. Nephron 1975:15:456-465.
4. Bareford D. Lucas GS. Stone PCW. Caldwell NM. McGonigle R. Stuart J: Erythrocyte defor-mability in chronic renal failure. Clin Hcmor-heol 1986;6:501-510.
5. Duchesnc-Guegucn M, Durand F. Le Pogamp P. Garry J. Le Goff MC. Joyeux V. Chevet D. Gcnetet B: Study of hcmorheological parameters in patients with chronic renal failure and evolution of those parameters in the course of dialysis treatment. Clin Hcmorheol 1988:8: 407-414.
6. Inaucn W, Stacubli M. Descocudres C. Galeaz-zi RL. Straub W: Erythrocyte deformability in dialyscd and non-dialysed uremic patients. Eur J Clin Invest 1982:12:173-176.
7. Koppensteiner R, Stockenhuber F. Jahn C, Balcke P. Minar E. Ehringer H: Changes in determinants of blood rheologv during treatment with hemodialysis and recombinant human erythropoietin. Br Med J 1990:300:1626- 1627.
8. Nenci G. Berrettini M. Agnelli G. Parise P, Buoncristianj U, Ballatori E: EfTcct of peritoneal dialysis, hemodialysis and kidney transplantation on blood platelet function: Platelet aggregation by ADP and epinephrine. Nephron 1979:23:287-292.
9. Clauss A: Gcrinnungsphysioloischc Schncllme-thode zur Bestimmung des Fibrinogens. Acta Haematol 1957;17:235-237.
10. Schmid-Schonbein H. Volger E, Teitcl P. Kie-scwcttcr H, Daucr U, Hcilmann L: New he-morheological techniques for routine laboratory. Clin Hemorhcol 1982;2:93-98.
11. Klosc HJ: A rhcologieal method for quantification of platelet aggregation (PA) in vitro and its kinetics under defined flow conditions. Throntb Res 1975:7:261-272.
12. Harkness J: A new instrument for measurement of plasma viscosity. Lancet 1963:vol ii:280- 281.
13. Reizenstein P: The haematological stress syndrome. Br J Haematol 1979;43:329-334.
14. Stuart J. George AJ. Davies AJ. Aukland A, Hurlow RA: Haematological sires syndrome in atherosclerosis. J Clin Pathol 1981:34:464-467.
15. Stuart J: The acute-phase reaction and hacma-tological stress syndrome in vascular disease. Int J Microcirc Clin Exp 1984:3:115-129.
16. Vanrentcrghcm Y, Lerut T, Rocls L, Gruwez J, Michielscn P. Gresclc P. Colucci M. Dcckmyn H. Amout J. Vermylcn J: Thromboembolic complications and haemostatic changes in cyclosporin-treated cadaveric kidney allograft recipients. Lancet 1985; vol i:999-1002.
17. Colley CM. Heck A. Goode AW. Muller BR. Myers MA: Early time course of the acute phase protein response in man. J Clin Pathol 1983:36:203-207.
18. Meade TW, Chakrabarti R. Haines AP. North WRS. Stirling Y. Thompson SG: Hemostatic function and cardiovascular death: Early results of a prospective study. Lancet 1980;vol i: 1050-1054.
19. Kanncl WB. Wolf PA. Castelli WP. D'Agostino RB: Fibrinogen and risk of cardiovascular disease: The Framingham Study. JAMA 1987: 258:1183-1186.
20. Wilhelmsen L. Svärdsudd K, Korsan-Bengtsen K. Larsson B, Wclin L, Tibblib G: Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 1984:31 1:501-505.
21. Meade TW. Brozovic M. Chakrabarti RR. Haines AP. Imeson JD. Mellows S. Miller GJ. North WRS. Stirling Y. Thompson SG: Haemostatic function and ischaemic heart disease: Principal results of te Northwick Park Heart Study. Lancet 1986;vol ii:533-537.
22. Brunner FP. Broycr M, Brvngcr H. Challa S. Dykes SR. Fassbinder W. Oulcs R, Rizzoni G. Selwood NH, Wing AJ: Registry report. Survival on renal replacement therapy: Data from the EDTA Registry. Nephrol Dial Transplant 1980;2:109-122.
23. Sun CH. Ward HJ. Paul WL. Koyle MA. Yana-gawa N. Lee BN: Scrum ervhtropoielin levels after renal transplantation. N Engl J Med 1989; 321:151-157.
24. Lindsay RM. Moorthy AV. Koens F. Linton AL: Platelet function in dialvzcd and non-dia-lyzcd patients with chronic renal failure. Clin Nephrol 1975:4:52-57.